rdf:type |
|
lifeskim:mentions |
umls-concept:C0016360,
umls-concept:C0017262,
umls-concept:C0023413,
umls-concept:C0030705,
umls-concept:C0069717,
umls-concept:C0079419,
umls-concept:C0185117,
umls-concept:C0242793,
umls-concept:C0278480,
umls-concept:C0332293,
umls-concept:C0920269,
umls-concept:C2911684
|
pubmed:issue |
4
|
pubmed:dateCreated |
2010-3-26
|
pubmed:abstractText |
The aim was to determine the values of p53 tumour expression and microsatellite instability (MSI) phenotype to predict benefit from adjuvant chemotherapy of colon cancer by 5-fluorouracil and leucovorin (FL) alone or with oxaliplatin (FOLFOX).
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
1569-8041
|
pubmed:author |
pubmed-author:Cuilliere-DartiguesPP,
pubmed-author:DumontSS,
pubmed-author:DuvalAA,
pubmed-author:FléjouJ-FJF,
pubmed-author:GayetBB,
pubmed-author:GuillouxAA,
pubmed-author:LouvetCC,
pubmed-author:ParrJJ,
pubmed-author:PratHH,
pubmed-author:TiretEE,
pubmed-author:ValidirePP,
pubmed-author:ZaananAA,
pubmed-author:de GramontAA
|
pubmed:issnType |
Electronic
|
pubmed:volume |
21
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
772-80
|
pubmed:meshHeading |
pubmed-meshheading:19833818-Adenocarcinoma,
pubmed-meshheading:19833818-Adult,
pubmed-meshheading:19833818-Aged,
pubmed-meshheading:19833818-Aged, 80 and over,
pubmed-meshheading:19833818-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:19833818-Colonic Neoplasms,
pubmed-meshheading:19833818-Disease-Free Survival,
pubmed-meshheading:19833818-Female,
pubmed-meshheading:19833818-Fluorouracil,
pubmed-meshheading:19833818-Humans,
pubmed-meshheading:19833818-Leucovorin,
pubmed-meshheading:19833818-Male,
pubmed-meshheading:19833818-Microsatellite Instability,
pubmed-meshheading:19833818-Middle Aged,
pubmed-meshheading:19833818-Neoplasm Staging,
pubmed-meshheading:19833818-Organoplatinum Compounds,
pubmed-meshheading:19833818-Retrospective Studies,
pubmed-meshheading:19833818-Tumor Suppressor Protein p53
|
pubmed:year |
2010
|
pubmed:articleTitle |
Impact of p53 expression and microsatellite instability on stage III colon cancer disease-free survival in patients treated by 5-fluorouracil and leucovorin with or without oxaliplatin.
|
pubmed:affiliation |
INSERM, UMR_S 938, Saint-Antoine Research Centre, 184 rue du Faubourg Saint-Antoine, Paris cedex 12, France.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't,
Evaluation Studies
|